The localization of AKT1 and ESR1 in tumor cells, alongside SRC and IL6 in myeloid cells, highlights potential mechanisms through which the decoction impacts tumor-immune interactions, potentially altering immune surveillance and tumor progression in high-risk locally advanced NPC. The gene discussed is ESR1; the disease is nasopharyngeal carcinoma.